Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 2, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-000983.pdf 0001562180-24-000983.rtf 0001562180-24-000983.xls View HTML
February 29, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-001992.pdf 0001562180-24-001992.rtf 0001562180-24-001992.xls View HTML
February 29, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-001993.pdf 0001562180-24-001993.rtf 0001562180-24-001993.xls View HTML
February 29, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-001995.pdf 0001562180-24-001995.rtf 0001562180-24-001995.xls View HTML
February 29, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-001994.pdf 0001562180-24-001994.rtf 0001562180-24-001994.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002022.pdf 0001562180-24-002022.rtf 0001562180-24-002022.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002020.pdf 0001562180-24-002020.rtf 0001562180-24-002020.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002021.pdf 0001562180-24-002021.rtf 0001562180-24-002021.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002023.pdf 0001562180-24-002023.rtf 0001562180-24-002023.xls View HTML
January 5, 2015	4/A	Amendment to a previously filed 4	0001209191-15-000984.pdf 0001209191-15-000984.rtf 0001209191-15-000984.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax